Cargando…

Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

Recently, the US Food and Drug Administration and European Medicines Agency issued warnings on the use of dolutegravir and darunavir/cobicistat for treatment of pregnant women living with human immunodeficiency virus (HIV). It took 3–5 years to identify the risks associated with the use of these ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colbers, Angela, Mirochnick, Mark, Schalkwijk, Stein, Penazzato, Martina, Townsend, Claire, Burger, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743813/ https://www.ncbi.nlm.nih.gov/pubmed/30783649 http://dx.doi.org/10.1093/cid/ciz121

Ejemplares similares

Importance of Inclusion of Pregnant and Breastfeeding Women in COVID-19 Therapeutic Trials
por: LaCourse, Sylvia, et al.
Publicado: (2020)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
por: Mulligan, Nikki, et al.
Publicado: (2016)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Accelerating drug discovery for pregnant and lactating women living with HIV
por: Hoffman, Risa M, et al.
Publicado: (2021)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
por: Schalkwijk, Stein, et al.
Publicado: (2018)

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
por: Bukkems, Vera E., et al.
Publicado: (2020)

HIV misdiagnosis in paediatrics: unpacking the complexity
por: Sacks, Emma, et al.
Publicado: (2017)

COVID-19 vaccination in pregnant and lactating diabetic women
por: Sculli, Maria Angela, et al.
Publicado: (2021)

TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence
por: Mathad, Jyoti S, et al.
Publicado: (2020)

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
por: Waalewijn, Hylke, et al.
Publicado: (2019)

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network
por: Bukkems, Vera, et al.
Publicado: (2020)

Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
por: White, Rhonda R., et al.
Publicado: (2023)

Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network( )
por: Bukkems, Vera E, et al.
Publicado: (2021)

Blood Drain: Soil-Transmitted Helminths and Anemia in Pregnant Women
por: Gyorkos, Theresa W., et al.
Publicado: (2014)

Scabies-infested pregnant women: A critical therapeutic challenge
por: Weill, Amandine, et al.
Publicado: (2021)

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV
por: Bukkems, Vera E., et al.
Publicado: (2021)

Marketing Breastfeeding Substitutes: A Discussion Document
por: Becker, Genevieve E
Publicado: (2020)

Hepatitis C elimination in people living with HIV – the importance of biomedical and behavioural interventions
por: van Santen, Daniela K, et al.
Publicado: (2020)

Establishing and Expecting a Culture of Support for Breastfeeding Cardiology Fellows
por: Kay, Jenna, et al.
Publicado: (2019)

Congenital Chagas Disease: Recommendations for Diagnosis, Treatment and Control of Newborns, Siblings and Pregnant Women
por: Carlier, Yves, et al.
Publicado: (2011)

HIV Surveillance Among Pregnant Women Attending Antenatal Clinics: Evolution and Current Direction
por: Dee, Jacob, et al.
Publicado: (2017)

Agness Mseteka: Maternity Waiting Home Caretaker and Protector of Pregnant Women in Rural Zambia
por: Buser, Julie M., et al.
Publicado: (2021)

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities
por: Nachman, Sharon, et al.
Publicado: (2019)

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
por: Carlier, Yves, et al.
Publicado: (2019)

The Enigma of the Human Immunodeficiency Virus (HIV) Epidemic in China
por: Wu, Zunyou, et al.
Publicado: (2020)

Treatment of Pregnant Women with Ivermectin during Mass Drug Distribution: Time to Investigate Its Safety and Potential Benefits
por: Erber, Astrid Christine, et al.
Publicado: (2021)

Ethical, strategic and meaningful involvement of women living with HIV starts at the beginning
por: Namiba, Angelina, et al.
Publicado: (2016)

The menopause transition in women living with HIV: current evidence and future avenues of research
por: Tariq, Shema, et al.
Publicado: (2016)

Ask women living with HIV what’s needed to achieve safe pregnancies in serodifferent relationships
por: Orza, Luisa, et al.
Publicado: (2017)

The ‘post-condom era’ or the urgent need to provide effective contraception for women living with HIV
por: Aebi-Popp, Karoline
Publicado: (2017)

Fetal outcome in the critically ill pregnant woman
por: Aoyama, Kazuyoshi, et al.
Publicado: (2014)

Is Human Immunodeficiency Virus Infection a Risk Factor for Strongyloides stercoralis Hyperinfection and Dissemination
por: Siegel, Marc O., et al.
Publicado: (2012)

Simplifying screening for Trypanosoma cruzi in pregnant persons and their infants
por: Buekens, Pierre, et al.
Publicado: (2023)

To effectively reduce violence against women living with HIV, we must make healthcare systems places of safety
por: Brion, Sophie O., et al.
Publicado: (2021)

The Importance of Pathogen Load
por: Cunnington, Aubrey J.
Publicado: (2015)

Engaging the community of women living with HIV to tailor and accelerate ARV research for pregnant and breastfeeding women
por: Clayden, Polly, et al.
Publicado: (2022)

The Importance of Heterogeneity to the Epidemiology of Tuberculosis
por: Trauer, James M, et al.
Publicado: (2019)

Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection
por: Abrams, Elaine J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_df54t0q992ulk07e6rlgtfrkbp